We use AI to unlock the immune system’s deep intelligence, enabling us to diagnose hard-to-detect diseases and develop new, targeted therapies for conditions that have long been underserved.
Our platform
MyImmune’s AI-powered platform leverages adaptive immune networks to decode the immune system, transforming biological data into actionable insights that accelerate diagnostics and therapeutic discovery.
Our mission
Driven by a passion for innovation, MyImmune’s team works at the intersection of AI and immunology to develop advanced diagnostics and therapies that improve patient care.
Partnerships
Partner with MyImmune to unlock the full potential of the immune system for earlier disease detection, advanced therapeutic discovery, and deeper patient immune profiling
Our Science
“MyImmune’s approach to clustering BCR and TCR repertoire data, developed in Daron Standley’s lab at Osaka University, opens up new avenues for biomedical research.
Disease Detection
Leveraging adaptive immune receptor paratope networks, MyImmune’s platform can achieve highly accurate detection of cancer, autoimmune, and infectious diseases, while uncovering a reservoir of therapeutic immune cells in healthy individuals, opening new possibilities for precision diagnostics and treatment.
Antibody Clustering
Using a novel clustering method based on CDR sequences, MyImmune’s platform successfully identifies antigen-specific and neutralizing antibodies, offering a powerful tool for MyImmune to accelerate the discovery of therapeutic antibodies for diseases like cancer and autoimmune disorders.
Team
Florian Hauer, PhD
Founder and CEO
Prof Daron Standley, PhD
Founder and Chief Scientific Advisor
Ayan Sengupta
Founder and CTO
Debottam Upadhyaya
Lead Fullstack Engineer
Mara Anais Llamas Covarrubias, PhD
Scientist
Guy Cavet, PhD
Board of Directors
Maximilian Schmid, MD
Advisor
Get in touch to learn more!
Leave a message
ABOUT US
Imprint
Terms and Conditions
Privacy
FOLLOW US